NICRC Patient Information

The Trastuzumab (Herceptin®) Studies: What it Means for You (157kb) This fact sheet is of particular interest to newly diagnosed breast cancer patients who have HER2 positive tumors. The Bevacizumab (Avastin®) Study: What it Means for You (147kb) This fact sheet is of particular interest to patients who are newly diagnosed with a locally recurrent or metastatic breast cancer. The Letrozole Study: What it Means for Me (259kb) Randomized trial of Letrozole in postmenopausal women after 5 years of Tamoxifen. The Exemestane Study: What it Means for Me (259kb) This study is of particular interest to breast cancer survivors who have been on Tamoxifen. Cancer Information You Want to Know Risk Factors- Breast Cancer/Prostate Cancer NCI Issues Clinical Announcement for Preferred Method of Treatment for Advanced Ovarian Cancer Northern Indiana Cancer Research Consortium Participated in Clinical Trial Treatment Information for Advanced Ovarian cancer. Information from the Eastern Cooperative Oncology Group (ECOG) on cancer clinical trials: NCCCP Resource Guide NCI Community Cancer Centers Program Resource Guide Someone I Love Has Cancer The Family Healing Program is for the entire immediate family